What does Lars Rebien Sørensen have in common with Presidents Franklin D. Roosevelt, Ronald Regan and Bill Clinton? Or Archbishop Desmond Tutu, Robert Kennedy, George Soros, Henry Kissinger and Ted Turner for that matter?
They have all been invited to speak at The City Club of Cleveland – a politically independent debate ground, where the speaker offers a few opening remarks, before the floor is opened to questions from the audience.
At the speaking engagement, Novo Nordisk’s CEO was asked about his opinion on President Barack Obama’s controversial Affordable Care Act, Obamacare, writes the Huffington Post.
You can send a man to the moon
The Danish company obviously has its own interests to look out for in relation to the political environment in the US, and Lars Rebien repeatedly stressed that his words reflected his own, personal opinion.
“There’s no way you can get away from not offering health services to everyone. You have to excuse me, this is my cultural upbringing. To me it’s inconceivable. It’s not dignified not to have people covered by basic health care services. I can’t see you can roll that back,” he started out by saying.
“The next thing is then; can you put in place insurance schemes that are priced in a way where it is not going to be detrimental to small businesses and to private contractors, thereby putting them out of business? This is of course where it’s going to get tricky. But I’m optimistic. I’ve understood there has been some system glitches in starting up the exchanges, but I have to believe that if you can send a man to the moon, you’re going to be able to put a software system together where you can register insurance,” he said, adding:
“I know it’s complicated, and all of us, who work in companies, we have tried to introduce new IDP systems, and it’s always failing and it always becomes more expensive and complicated, but you can do it. I think you just have to get on with it.”
See a full-length video of the debate meeting from Huffington Post here.
- translated by Martin Havtorn Petersen
Want to receive the latest news from Medwatch straight in your e-mail inbox? Sign up for our free english newsletter below.
Mere fra MedWatch
Zealand Pharma hentede den seneste uge 786 mio kr. gennem en rettet emission, mens biotekselskabet Biograil hev et partnerskab med den amerikanske gigant Eli Lilly i land. Og så blev der udskrevet folketingsvalg, som fik særligt ét spørgsmål til at fylde i vælgernes bevidsthed. Gik du glip af noget?